Seroatlas · Human Serome Atlas

MAL

Myelin and lymphocyte protein

Also known as: MAL_HUMAN, MVP17, VIP17

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P21145
Gene
MAL
Ensembl
ENSG00000172005
Chromosome
2
Canonical length
153 aa
Protein class
Predicted membrane proteins, Transporters
Subcellular location
Golgi apparatus,Centrosome,Basal body

OverviewNCBI Gene

The protein encoded by this gene is a highly hydrophobic integral membrane protein belonging to the MAL family of proteolipids. The protein has been localized to the endoplasmic reticulum of T-cells and is a candidate linker protein in T-cell signal transduction. In addition, this proteolipid is localized in compact myelin of cells in the nervous system and has been implicated in myelin biogenesis and/or function. The protein plays a role in the formation, stabilization and maintenance of glycosphingolipid-enriched membrane microdomains. Down-regulation of this gene has been associated with a variety of human epithelial malignancies. Alternative splicing produces four transcript variants which vary from each other by the presence or absence of alternatively spliced exons 2 and 3. [provided by RefSeq, May 2012]

Canonical amino-acid sequenceUniProt

153 residues, UniProt reviewed canonical sequence.

>P21145|MAL
     1  MAPAAATGGS TLPSGFSVFT TLPDLLFIFE FIFGGLVWIL VASSLVPWPL VQGWVMFVSV
    61  FCFVATTTLI ILYIIGAHGG ETSWVTLDAA YHCTAALFYL SASVLEALAT ITMQDGFTYR
   121  HYHENIAAVV FSYIATLLYV VHAVFSLIRW KSS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MAL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
4
Mean surface accessibility (rSASA)
0.29
Highest tissue expression
2,851 nTPM

Expression across tissuesHPA

Tissue

  • esophagus: 2,851 nTPM
  • vagina: 836 nTPM
  • cervix: 687 nTPM
  • salivary gland: 480 nTPM
  • kidney: 398 nTPM
  • spinal cord: 343 nTPM

Single-cell type

  • esophageal apical cells: 40,846 nCPM
  • suprabasal keratinocytes: 1,225 nCPM
  • esophageal suprabasal cells: 1,112 nCPM
  • schwann cells: 462 nCPM
  • loop of henle epithelial cells: 414 nCPM
  • ocular epithelial cells: 380 nCPM

Immune cell

  • naive CD4 T-cell: 294 nTPM
  • T-reg: 234 nTPM
  • memory CD4 T-cell: 218 nTPM
  • naive CD8 T-cell: 139 nTPM
  • total PBMC: 71 nTPM
  • memory CD8 T-cell: 38 nTPM

Brain region

  • white matter: 564 nTPM
  • basal ganglia: 342 nTPM
  • thalamus: 277 nTPM
  • cerebral cortex: 270 nTPM
  • medulla oblongata: 235 nTPM
  • midbrain: 234 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about MAL.

Disease | AllUniProt

Conditions MAL is implicated in, by any mechanism.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.51
gnomAD pLI
0.83
gnomAD missense Z
0.41
DepMap mean gene effect
-0.15
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of MAL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MAL as an antibody target. Whether an autoantibody or antibody against MAL could matter depends on whether native MAL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MAL is annotated at the cell surface, where native MAL is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label MAL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MAL. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...